期刊文献+

益气养阴法对肺癌患者外周血肿瘤免疫逃逸相关因子的影响 被引量:11

Effect of Therapy of Invigorating Qi and Nourishing Yin on Tumor Immune Escape Related Factors in Peripheral Blood of Patients with Lung Cancer
下载PDF
导出
摘要 目的:观察益气养阴法对肺癌免疫逃逸的干预作用。方法:采用前瞻性随机对照研究方法,将60例中晚期非小细胞肺癌气阴两虚型患者随机分为治疗组(n=30)和对照组(n=30),观察治疗前后外周血CD4+CD25+Tr、CD8+CD28+Tc、IL-10、sIL-2R、VEGF、sCD44v6、TGFβ1表达的水平变化,并从肺癌患者瘤体变化、KPS评分、中医证候疗效方面评价肺积方临床疗效。结果:与对照组相比,治疗组外周血CD4+CD25+Tr、VEGF、sCD44v6、TGFβ1、IL-10、sIL-2R水平降低,CD8+CD28+Tc水平升高;在瘤灶的稳定率方面,治疗组优于对照组;治疗组Karnofsky评分改善情况明显优于对照组;治疗组气阴两虚证候改善明显优于对照组。结论:益气养阴法可干预肺癌免疫逃逸,恢复机体的免疫监视作用,提高临床疗效。 Objective: To evaluate the intervention effect of therapy of invigorating qi and nourishing yin on tumor immune escape. Methods: In the perspective randomized control study, sixty cases of advanced none-small cell lung cancer (NSCLC) with deficiency of both qi and yin were randomly divided into two groups: treatment group (n=30) and control group (n=30).Treatment group was given "Feiji Recipe" in combination with chemotherapy, and control group received chemotherapy only. The efficacies were assessed by short-term efficacy, Karnofsky performance score, the change of symptoms of traditional Chinese medicine. The change of levels of CD4^+CD25^+Tr, IL-10, VEGF, sCD44v6 and TGFβ1 in peripheral blood were observed. Results: In comparison with chemotherapy, therapy of invigorating qi and nourishing yin down-regulated the levels of CD4^+CD25^+Tr, VEGF, sCD44v6, TGFβ1, IL-10, improved the short-term efficacy, Karnofsky performance scores and symptoms of traditional Chinese medicine. Conclusions: Therapy of invigorating qi and nourishing yin may intervene in tumor immune escape of patients with NSCLC on multi-pathway.
出处 《上海中医药大学学报》 CAS 2007年第3期48-51,共4页 Academic Journal of Shanghai University of Traditional Chinese Medicine
关键词 肺肿瘤 益气养阴法 免疫逃逸 临床研究 None-small cell lung cancer therapy of invigorating qi and nourishing yin immune escape clinical observation
  • 相关文献

参考文献21

  • 1Burnet FM. The concept of immunological surveillance [J]. Prog Exp Tumor Res, 1970, (13) : 1.
  • 2Thomas L. Discussion [A]. In: Lawrence HS. Cellular and humoral aspects of the hypersensitive states [M]. New York: Hoeber-Harper, 1959: 529-532.
  • 3Steinman RM, Mellman I.Immunotherapy: bewitched, bothered,and bewildered no more[J]. Science, 2004, 305 (5681) : 197-200.
  • 4Pawelec G. Immunotherapy and immunoselection-tumour escape as the final hurdle [J] .FEBS Lett, 2004, 567 (1) : 63-66.
  • 5中国抗癌协会.新编常见恶性肿瘤诊治规范·第九分册[S].北京:中国协和医科大学出版社,1997:737—781.
  • 6国际抗癌联盟AJCCASICC.肺癌分期(97国际肺癌分期)标准[A].见:周际昌.实用肿瘤内科学[M].北京:人民卫生出版社,1999:23.
  • 7沈自尹 王文健.中医虚证辨证参考标准[J].中西医结合杂志,1986,6(10):598-598.
  • 8Therasse P, Arbuck SG, Eisenhauer EA, et al. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada [J]. J Natl Cancer Inst. 2000,92 (3):205-216.
  • 9Kruger C, Greten TF, Korangy F. Immune based therapies in cancer [J]. Histol Histopathol, 2007,22 (6): 687-696.
  • 10Gabrilovich D,Pisarev V. Tumor escape from immune response: mechanisms and targets of activity [J]. Curr Drug Targets, 2003,4 (7) : 525-536.

二级参考文献46

  • 1Lou W, Krill D, Dhir R, et al. Methylation of the CD44 metastasis suppressor gene in human prostate cancer. Cancer Res, 1999, 59(10): 2329-2331.
  • 2Allouche M, Charrad RS, Bettaieb A, et al. Ligation of the CD44 adhesion molecule inhibits drug-induced alxoptosis in human myeloid leukemia cellsD. Blood, 2000, 96(3) : 1187-1190.
  • 3Hogerkorp CM,Bilke S, Breslin T, et al. CD44-stimulated human B cell express transcripts specifically involved in immunodulation and inflammation as analyzed by DNA microarrays. Blood, 2003,101(6) :2307-2313.
  • 4McKallip RJ, Do Y, Fisher MT, et al. Role of CD44 in activation-induced cell death: CD44-deficient mice exhibit enhanced T cell response to conventional and superantigens. Int Immunol, 2002, 14(9) : 1015-1026.
  • 5Fujisaki T, Tanaka Y, Fujii K, et al. CD44 stimulation induces integrin-mediated adhesion of colon cancer cell lines to endothelial cells by up-regulation of integrins and c-Met and activation of integrins.Cancer Re.s, 1999,59(17) : 4427-4434.
  • 6Takahashi K, Eto H, Tanabe KK. Involvement of CD44 in matrix metalloproteinase-2 regulation in human melanoma ceils. Int J Cancer, 1999, 80(3) : 387-395.
  • 7Kajita M, ltoh Y, Chiba T, et al. Membrane-type 1 matrix metalloproteinase cleaves CD44 and promotes cell migration. J Cell Biol,2001, 153(5): 893-904.
  • 8Dmrguignon LY, Zhu H, Shao L, et al. CD44 interaction with tiaml promotes Racl signaling and hyaluronic acid-mediated breast tumor cell migration. J Biol Chem, 2000, 275(3) : 1829-1838.
  • 9Weber GF, Bronson RT, Ilagan J, et al. Absence of the CIN4 gene prevents ,sarcoma metastasis. Cancer Res, 2002, 62 ( 8 ) : 2281-2286.
  • 10Wimmenauer S, Steiert A, Wolff Vorbeck G, et al. Influence of cytokines on the expression of fas ligand and CD44 splice variants in colon carcinoma cells. Tumour Biol, 1999,20(6) : 294-303.

共引文献589

同被引文献181

引证文献11

二级引证文献61

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部